As of March 31, 2026, Aatmaj Healthcare Limited carries a market capitalization of 414.71M, placing it among publicly traded companies globally. Its enterprise value stands at 508.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 414.71M |
| Enterprise Value | 508.08M |
As of March 31, 2026, Aatmaj Healthcare Limited has 22.60M shares outstanding.
| Shares Outstanding | 22.60M |
As of March 31, 2026, Aatmaj Healthcare Limited trades at a trailing price-to-earnings ratio of 58.13. The price-to-sales ratio is 1.71, and the price-to-book ratio stands at 0.82.
| PE Ratio | 58.13 |
| PS Ratio | 1.71 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | 5.87 |
| P/OCF Ratio | 5.87 |
As of March 31, 2026, Aatmaj Healthcare Limited trades at an EV/EBITDA multiple of 21.51 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 36.58 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Aatmaj Healthcare Limited trades at an EV/FCF ratio of 6.29, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 508.08M versus a market cap of 414.71M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 2.09 |
| EV / EBITDA | 21.51 |
| EV / EBIT | 36.58 |
| EV / FCF | 6.29 |
As of March 31, 2026, Aatmaj Healthcare Limited maintains a current ratio of 2.90, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.37, indicating elevated leverage, while an interest coverage ratio of 1.72 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.90 |
| Quick Ratio | 0.73 |
| Debt / Equity | 41.37 |
| Debt / EBITDA | 8.90 |
| Interest Coverage | 1.72 |
These figures cover the twelve months ended March 31, 2026. The company generates approximately 810,600.00 in revenue per employee across its workforce of 300.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 810,600.00 |
| Employee Count | 300.00 |
Over the twelve months ended March 31, 2026, Aatmaj Healthcare Limited recorded 2.56M in income tax expense. That works out to an effective tax rate of 26.41, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 9.69M, leaving 7.13M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 2.56M |
| Effective Tax Rate | 26.41 |
As of the close on November 17, 2026, Aatmaj Healthcare Limited's stock has gained approximately 30.17% over the past 52 weeks. The 50-day moving average sits at 21.57, while the 200-day moving average is 20.85.
| 52-Week Price Change | 30.17% |
| 50-Day Moving Average | 21.57 |
| 200-Day Moving Average | 20.85 |
Over the twelve months ended March 31, 2026, Aatmaj Healthcare Limited generated 243.18M in revenue and converted that into 7.13M in net income, yielding earnings per share of 0.32. EBITDA reached 23.62M, while operating income came in at 13.89M.
| Revenue | 243.18M |
| Gross Profit | 216.92M |
| Operating Income | 13.89M |
| Pretax Income | 9.69M |
| Net Income | 7.13M |
| EBITDA | 23.62M |
| EBIT | 13.89M |
| Earnings Per Share (EPS) | 0.32 |
As of March 31, 2026, Aatmaj Healthcare Limited holds 116.95M in cash and equivalents against 210.32M in total debt, resulting in a net debt position of 93.37M. Total book value stands at 508.35M, with working capital of 305.68M providing operational flexibility.
| Cash & Cash Equivalents | 116.95M |
| Total Debt | 210.32M |
| Net Debt | 93.37M |
| Equity (Book Value) | 508.35M |
| Book Value Per Share | 22.49 |
| Working Capital | 305.68M |
Aatmaj Healthcare Limited produced 70.68M in operating cash flow over the twelve months ended March 31, 2026.
| Operating Cash Flow | 70.68M |
| Free Cash Flow | 70.68M |
| FCF Per Share | 3.13 |
Over the twelve months ended March 31, 2026, Aatmaj Healthcare Limited posted a gross margin of 89.20, reflecting its pricing power and cost economics. The operating margin of 5.71 and net profit margin of 2.93 provide insight into operational efficiency.
| Gross Margin | 89.20 |
| Operating Margin | 5.71 |
| Pretax Margin | 3.99 |
| Profit Margin | 2.93 |
| EBITDA Margin | 9.71 |
These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 17.04, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -11.69, meaning Aatmaj Healthcare Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -11.69 |
| FCF Yield | 17.04 |
Already premium?